Multiple sclerosis: a two-stage disease (original) (raw)

• News & Views
• Published: 01 September 2001

Nature Immunology volume 2, pages 762–764 (2001)Cite this article

• 4566 Accesses
• 524 Citations
• 9 Altmetric
• Metrics details

The pathogenesis of multiple sclerosis consists of an inflammatory and neurodegnerative phase. Better understanding of these stages has aided the development of specific therapeutic targets.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

• STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis

  • Junjie Zhao
  • , Yun Liao
  • … Zizhen Kang
    Journal of Neuroinflammation Open Access 20 April 2021

• MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1

  • Bowen Liu
  • , Yafei Ding
  • … Jinjian Yang
    BMC Urology Open Access 07 December 2020

• Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years

  • Irene Pulido-Valdeolivas
  • , Magí Andorrà
  • … Elena H. Martinez-Lapiscina
    Scientific Reports Open Access 07 August 2020

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Figure 1: The two stages of the progression of MS.

The alternative text for this image may have been generated using AI.

Bob Crimi

References

1. Trapp, B. D. et al. New Engl. J. Med. 338, 278–285 (1998).
   Article CAS PubMed Google Scholar
2. Loseff, N. A. et al. Brain 119, 701–708 (1996).
   Article Google Scholar
3. Haines, J. L. et al. Nature Genet. 13, 469–471 (1996).
   Article CAS PubMed Google Scholar
4. Ebers, G. C. et al. Nature Genet. 13, 472–476 (1996).
   Article CAS PubMed Google Scholar
5. Sawcer, S. et al. Nature Genet. 13, 464–468 (1996).
   Article CAS PubMed Google Scholar
6. Wucherpfennig, K. W. et al. J. Clin. Invest. 100, 1114–1122 (1997).
   Article CAS PubMed PubMed Central Google Scholar
7. Conlon, P., Oksenberg, J. R., Zhang, J. & Steinman, L. Neurobiol. Dis. 6, 149–166 (1999).
   Article CAS PubMed Google Scholar
8. Kappos, L. et al. Nature Med. 6, 1176–1182 (2000).
   Article CAS PubMed Google Scholar
9. Lucchinetti, C. F., Bruck, W., Rodriguez, M. & Lassmann, H. Brain Pathol. 6, 259–274 (1996).
   Article CAS PubMed Google Scholar
10. Pitt, D., Werner, P. & Raine, C. Nature Med. 6, 67–70 (2000).
    Article CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

1. Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, 94305, CA, USA
   Lawrence Steinman

Rights and permissions

About this article

Cite this article

Steinman, L. Multiple sclerosis: a two-stage disease.Nat Immunol 2, 762–764 (2001). https://doi.org/10.1038/ni0901-762

Download citation

• Issue date: 01 September 2001
• DOI: https://doi.org/10.1038/ni0901-762

This article is cited by